Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-14

Clinical Trial Update: Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ceftazidime-avibactam plus metronidazole versus meropenem in adults with complicated intra-abdominal infections has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meropenem (Meropenem)
  • ceftazidime-avibactam + metronidazole

Snippet

Sponsor: Pfizer | Conditions: Complicated Intra-abdominal Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-04-14